Search

everythinglearnresearchcommunity

for

Search:↓

CuATSM speeds up wound healing and reduces scarring.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Dermal EZH2 controls skin cell development and hair growth in mice.

RXRα is crucial for proper immune response and links diet to immune function.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Compounds from Ziziphus spina-christi roots show strong antibacterial and antioxidant potential.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Targeting ornithine decarboxylase can help prevent skin cancer.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.